10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.
10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood